Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 4Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × bazedoxifene × Clear all
NCT04821375 2025-10-29

Pilot Study of Bazedoxifene Plus Conjugated Estrogen on Imaging and Blood Biomarkers

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
16 enrolled
Breast

Breast Neoplasms

NCT02694809 2025-01-28

The PROMISE Study: Duavee in Women With DCIS

Northwestern University

Phase 2 Completed
142 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

NCT02448771 2022-10-24

A Study of Palbociclib in Combination With Bazedoxifene in Hormone Receptor Positive Breast Cancer

Dana-Farber Cancer Institute

Phase 1/2 Completed
36 enrolled 28 charts
Breast

Breast Neoplasms

NCT02729701 2022-03-09

Pilot Study of the Effect of Duavee® on Benign Breast Tissue Proliferation

University of Kansas Medical Center

Phase 2 Completed
28 enrolled 9 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡